Lipocine Inc (LPCN)

Mar 25, 2026

Gains Recap: Is Lipocine Inc a cyclical or defensive stockQuarterly Performance Summary & Weekly Stock Performance Updates - baoquankhu1.vn

Mar 25, 2026

Mar 22, 2026

Aug Mood: What is the Moat Score of Lipocine IncMarket Sentiment Summary & Daily Entry Point Trade Alerts - baoquankhu1.vn

Mar 22, 2026

Mar 22, 2026

Lipocine (NASDAQ:LPCN) Rating Increased to Hold at Wall Street Zen - MarketBeat

Mar 22, 2026

Mar 21, 2026

If You Invested $1,000 in Lipocine Inc (LPCN) - Stock Titan

Mar 21, 2026

Mar 17, 2026

Lipocine price target raised to $11 from $6.75 at Alliance Global - TipRanks

Mar 17, 2026

Mar 10, 2026

Lipocine Announces 2025 Financial Results and Progress on Postpartum Depression, Epilepsy, and Obesity Drug Pipeline - Minichart

Mar 10, 2026

Mar 10, 2026

Lipocine Inc. 2025 Annual Report: Innovative Oral Drug Delivery, CNS & Metabolic Pipeline, and R&D Highlights - Minichart

Mar 10, 2026

Mar 10, 2026

Lipocine Announces Financial Results for the Full Year Ended December 31, 2025 - The Herald Journal

Mar 10, 2026

Mar 10, 2026

Lipocine Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 10, 2026

Mar 10, 2026

Lipocine 2025 Financial Results: Q4 & Annual PerformanceNews and Statistics - IndexBox

Mar 10, 2026

Mar 10, 2026

Lipocine: Fourth Quarter Financial Results Overview - Bitget

Mar 10, 2026

Mar 10, 2026

Lipocine: Q4 Earnings Snapshot - Barchart

Mar 10, 2026

Mar 10, 2026

Lipocine (NASDAQ: LPCN) 2025 revenue falls to $2M with $9.6M loss - Stock Titan

Mar 10, 2026

Mar 10, 2026

LPCN: 2025 saw a net loss of $9.6M as revenue fell, with cash runway through Q1 2027 and ongoing R&D focus - TradingView

Mar 10, 2026

Mar 10, 2026

Lipocine 10-K: Revenue $2.0M, EPS (Basic) $(1.77) - TradingView

Mar 10, 2026

Mar 10, 2026

LPCN: Pipeline advanced and cash raised, but revenue dropped and net loss widened in 2025 - TradingView

Mar 10, 2026

Mar 09, 2026

Lipocine Inc expected to post a loss of 61 cents a shareEarnings Preview - TradingView

Mar 09, 2026

Mar 09, 2026

Is Lipocine Inc affected by consumer sentiment2026 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 09, 2026

Mar 06, 2026

AI Stocks: Will Lipocine Inc benefit from rate cuts2025 Support & Resistance & Daily Profit Maximizing Tips - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

Lipocine Stock Quote, Share Price, News and Analysis - Longbridge

Mar 05, 2026

Mar 05, 2026

Lipocine Files Prospectus to Enable $50M Stock Offering - The Globe and Mail

Mar 05, 2026

Mar 05, 2026

Lipocine (LPCN) Expected to Announce Earnings on Thursday - Defense World

Mar 05, 2026

Mar 04, 2026

Lipocine (LPCN) establishes $50M at-the-market common stock sales plan - Stock Titan

Mar 04, 2026

Mar 03, 2026

Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD) - Nasdaq

Mar 03, 2026

Feb 27, 2026

Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock? - Yahoo Finance

Feb 27, 2026

Feb 26, 2026

Lipocine Files For Common Stock Offering Of Up To $50 MillionSEC Filing - TradingView

Feb 26, 2026

Feb 26, 2026

LivePerson (NASDAQ: LPCN) increases ATM sales capacity to $50M - Stock Titan

Feb 26, 2026

Feb 26, 2026

Lipocine (LPCN) Jumps 5.5%: Does the Stock Have More Room to Grow? - Bitget

Feb 26, 2026

Feb 23, 2026

ETF Watch: Is Lipocine Inc a turnaround storyTreasury Yields & Daily Momentum Trading Reports - baoquankhu1.vn

Feb 23, 2026

Feb 22, 2026

Can Lipocine Inc. stock beat market expectations this quarterTreasury Yields & Short-Term High Return Ideas - mfd.ru

Feb 22, 2026

Feb 19, 2026

Lipocine completes patient visits in phase 3 trial for PPD treatment - Investing.com Australia

Feb 19, 2026

Feb 18, 2026

Lipocine completes patient visits in phase 3 trial for PPD treatment By Investing.com - Investing.com South Africa

Feb 18, 2026

Feb 18, 2026

Lipocine Completes Phase 3 Trial for Postpartum Depression - TipRanks

Feb 18, 2026

Feb 18, 2026

Lipocine (NASDAQ: LPCN) files updated corporate investor presentation - Stock Titan

Feb 18, 2026

Feb 16, 2026

Is Lipocine Inc. stock a buy on dips2025 Key Lessons & Proven Capital Preservation Tips - mfd.ru

Feb 16, 2026

Feb 15, 2026

Is Lipocine Inc. a potential multi baggerMarket Volume Summary & Low Drawdown Momentum Ideas - mfd.ru

Feb 15, 2026

Feb 14, 2026

Lipocine Announces Late Breaking Oral Presentation of Data from - GuruFocus

Feb 14, 2026

Feb 12, 2026

Buy Rating Maintained on Lipocine Inc. (LPCN) as Target Climbs to $15 - Finviz

Feb 12, 2026

Feb 11, 2026

Does Lipocine Inc. stock have upside surprise potential2025 Stock Rankings & Long Hold Capital Preservation Tips - mfd.ru

Feb 11, 2026

Feb 11, 2026

Why Lipocine Inc. stock is favored by top institutionsJuly 2025 WrapUp & Smart Allocation Stock Reports - mfd.ru

Feb 11, 2026

Feb 09, 2026

S P Trends: Does Lipocine Inc offer margin of safetyMarket Activity Summary & Short-Term High Return Ideas - baoquankhu1.vn

Feb 09, 2026

Feb 06, 2026

Lipocine Announces Positive Interim Results for PPD Trial - MSN

Feb 06, 2026

Feb 04, 2026

Lipocine (LPCN) Price Target Increased by 58.18% to 11.09 - Nasdaq

Feb 04, 2026

Feb 02, 2026

Market Moves: Can Lipocine Inc ride the EV waveJuly 2025 News Drivers & Precise Swing Trade Alerts - baoquankhu1.vn

Feb 02, 2026

Feb 01, 2026

EV Market: Is Lipocine Inc a cyclical or defensive stockPortfolio Value Report & Real-Time Buy Signal Alerts - baoquankhu1.vn

Feb 01, 2026

Jan 21, 2026

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress By Investing.com - Investing.com South Africa

Jan 21, 2026

Jan 21, 2026

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress - Investing.com India

Jan 21, 2026

Jan 21, 2026

Lipocine completes enrollment in phase 3 trial for PPD treatment By Investing.com - Investing.com South Africa

Jan 21, 2026

Jan 20, 2026

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug - TipRanks

Jan 20, 2026